This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

FDA Approves GE, Volcano Product

General Electric's (GE - Get Report) health care unit and the ultrasound company Volcano (VOLC) said Thursday that they received Food and Drug Administration clearance to use a new technique in GE's Innova line of medical-imaging systems.

GE shares edged higher, and Volcano shares rose nearly 2% on the news.

The decision allows GE Healthcare to integrate Volcano's intravascular ultrasound imaging capabilities with its Innova all-digital X-ray catheterization lab imaging system. The system is designed to give doctors a clearer view of certain heart functions than had previously been possible.

The new product, Innova IVUS, will also be smaller, lighter and less noisy than traditional platforms. It should shorten procedure times, improve the identification of artery diseases and assist in procedures including stent placement and assessment.

"This technological development heralds a new beginning for advanced, real-time imaging in the cardiac catheterization laboratory," Laura King, global vice president and general manager of GE Healthcare's interventional, cardiology and surgery unit, said in a statement.

Separately, GE Healthcare Financial Services and Capital Senior Living (CSU - Get Report) formed a new joint venture that has completed a $38.2 million acquisition of three senior housing communities in the metropolitan Indianapolis area.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
VOLC $17.99 0.06%
CSU $20.21 0.00%
GE $30.63 0.00%
AAPL $95.18 0.00%
FB $117.43 0.00%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs